Abstract
The neural basis of human memory is incredibly complex. We argue that the diversity of neural systems underlying various forms of memory suggests that any discussion of enhancing ‘memory’ per se is too broad, thus obfuscating the biopolitical debate about human enhancement. Memory can be differentiated into at least four major (and several minor) systems with largely dissociable (i.e., non-overlapping) neural substrates. We outline each system, and discuss both the practical and the ethical implications of these diverse neural substrates. In practice, distinct neural bases imply the possibility, and likely the necessity, of specific approaches for the safe and effective enhancement of various memory systems. In the debate over the ethical and social implications of enhancement technologies, this fine-grained perspective clarifies—and may partially mitigate—certain common concerns in enhancement debates, including issues related to safety, fairness, coercion, and authenticity. While many researchers certainly appreciate the neurobiological complexity of memory, the political debate tends to revolve around a monolithic one-size-fits-all conception. The overall project—exploring how human enhancement technologies affect society – stands to benefit from a deeper appreciation of memory’s neurobiological diversity.
References
Pope, A. W. (1711/2008). Essay on criticism: Forgotten Books.
Ponds, R.W., K.J. Commissaris, and J. Jolles. 1997. Prevalence and covariates of subjective forgetfulness in a normal population in The Netherlands. The International Journal of Aging and Human Development 45(3): 207–221.
Loftus, E.F. 2013. 25 years of eyewitness science…… finally pays off. Perspectives on Psychological Science 8(5): 556–557.
Reitz, C., and R. Mayeux. 2014. Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers. Biochemical pharmacology.
Schacter, D.L. 2002. The seven sins of memory: how the mind forgets and remembers: Houghton Mifflin Harcourt.
Bostrom, N., and A. Sandberg. 2009. Cognitive enhancement: methods, ethics, regulatory challenges. Science and Engineering Ethics 15(3): 311–341.
Cabrera, L.Y. 2011. Memory enhancement: the issues we should not forget about. Memory 22: 1.
Farah, M.J., J. Illes, R. Cook-Deegan, H. Gardner, E. Kandel, P. King, and P.R. Wolpe. 2004. Neurocognitive enhancement: what can we do and what should we do? Nature Reviews Neuroscience 5(5): 421–425.
Greely, H.T., B. Sahakian, J. Harris, R.C. Kessler, M. Gazzaniga, P. Campbell, and M.J. Farah. 2008. Towards responsible use of cognitive-enhancing drugs by the healthy. Nature 456(7223): 702–705.
Hildt, E., and A.G. Franke. 2013. Cognitive enhancement: an interdisciplinary perspective (Vol. 1): Springer Science & Business Media.
Hyman, S.E. 2011. Cognitive enhancement: promises and perils. Neuron 69(4): 595–598.
Liao, S.M., and A. Sandberg. 2008. The normativity of memory modification. Neuroethics 1(2): 85–99.
Sandberg, A. 2011. Cognition enhancement: upgrading the brain. In J. Savulescu, R. t. Meulen & G. Kahane (Eds.), Enhancing human capacities (pp. 71–91): Wiley-Blackwell.
de Quervain, D.J.-F., and A. Papassotiropoulos. 2006. Identification of a genetic cluster influencing memory performance and hippocampal activity in humans. Proceedings of the National Academy of Sciences of the United States of America 103(11): 4270–4274.
Fukuyama, F. 2003. Our posthuman future: Consequences of the biotechnology revolution: Macmillan.
Savulescu, J. 2006. Justice, fairness, and enhancement. Annals of the New York Academy of Sciences 1093(1): 321–338.
Cheng, S., and M. Werning. 2016. What is episodic memory if it is a natural kind? Synthese 193(5): 1345–1385.
Michaelian, K. 2011. Is memory a natural kind? Memory Studies 4(2): 170–189.
Michaelian, K. 2015. Opening the doors of memory: is declarative memory a natural kind? Wiley Interdisciplinary Reviews: Cognitive Science 6(6): 475–482.
Rupert, R.D. 2013. Memory, natural kinds, and cognitive extension; or, Martians don’t remember, and cognitive science is not about cognition. Review of Philosophy and Psychology 4(1): 25–47.
Cakic, V. 2009. Smart drugs for cognitive enhancement: ethical and pragmatic considerations in the era of cosmetic neurology. Journal of Medical Ethics 35(10): 611–615.
Chatterjee, A. 2004. Cosmetic neurology the controversy over enhancing movement, mentation, and mood. Neurology 63(6): 968–974.
Fitz, N.S., R. Nadler, P. Manogaran, E.W. Chong, and P.B. Reiner. 2014. Public attitudes toward cognitive enhancement. Neuroethics 7(2): 173–188.
Eichenbaum, H., and N. J. Cohen. 2001. From conditioning to conscious recollection: Memory systems of the brain: Oxford University Press.
McDonald, R.J., and N.M. White. 1993. A triple dissociation of memory systems: hippocampus, amygdala, and dorsal striatum. Behavioral Neuroscience 107(1): 3.
Poldrack, R.A., and M.G. Packard. 2003. Competition among multiple memory systems: converging evidence from animal and human brain studies. Neuropsychologia 41(3): 245–251.
Squire, L.R. 2004. Memory systems of the brain: a brief history and current perspective. Neurobiology of Learning and Memory 82(3): 171–177.
Squire, L.R., B. Knowlton, and G. Musen. 1993. The structure and organization of memory. Annual Review of Psychology 44(1): 453–495.
Tulving, E. 1985. How many memory systems are there? American Psychologist 40(4): 385.
Tulving, E., and D.L. Schacter. 1990. Priming and human memory systems. Science 247(4940): 301–306.
Schacter, D.L. 1990. Perceptual representation systems and implicit memory. Annals of the New York Academy of Sciences 608(1): 543–571.
Clark, R.E., and L.R. Squire. 1998. Classical conditioning and brain systems: the role of awareness. Science 280(5360): 77–81.
Rankin, C.H., T. Abrams, R.J. Barry, S. Bhatnagar, D.F. Clayton, J. Colombo, and S. Marsland. 2009. Habituation revisited: an updated and revised description of the behavioral characteristics of habituation. Neurobiology of Learning and Memory 92(2): 135–138.
Ji, R.-R., T. Kohno, K.A. Moore, and C.J. Woolf. 2003. Central sensitization and LTP: do pain and memory share similar mechanisms? Trends in Neurosciences 26(12): 696–705.
Baddeley, A. 1992. Working memory. Science 255(5044): 556–559.
Baddeley, A. 2012. Working memory: theories, models, and controversies. Annual Review of Psychology 63: 1–29.
Stanley, J., and J.W. Krakauer. 2013. Motor skill depends on knowledge of facts. Frontiers in Human Neuroscience 7(503): 1–11.
McGaugh, J.L. 2000. Memory--a century of consolidation. Science 287(5451): 248–251.
Moscovitch, M., R.S. Rosenbaum, A. Gilboa, D.R. Addis, R. Westmacott, C. Grady, and G. Winocur. 2005. Functional neuroanatomy of remote episodic, semantic and spatial memory: a unified account based on multiple trace theory. Journal of Anatomy 207(1): 35–66.
Winocur, G., and M. Moscovitch. 2011. Memory transformation and systems consolidation. [Research Support, Non-U.S. Gov't]. Journal of International Neuropsychological Society 17(5): 766–780. doi:10.1017/S1355617711000683.
Squire, L.R., C.E. Stark, and R.E. Clark. 2004. The medial temporal lobe. Annual Review of Neuroscience 27: 279–306.
Conway, M.A., and C.W. Pleydell-Pearce. 2000. The construction of autobiographical memories in the self-memory system. Psychological Review 107(2): 261.
Rubin, D.C. 2006. The basic-systems model of episodic memory. Perspectives on Psychological Science 1(4): 277–311.
Thompson, C. P., Skowronski, J. J., Larsen, S. F., and A. L. Betz. 2013. Autobiographical memory: Remembering what and remembering when: Psychology Press.
Milner, B., S. Corkin, and H.-L. Teuber. 1968. Further analysis of the hippocampal amnesic syndrome: 14-year follow-up study of HM. Neuropsychologia 6(3): 215–234.
Squire, L.R. 2009. The legacy of patient HM for neuroscience. Neuron 61(1): 6–9.
Kesner, R.P., B.L. Bolland, and M. Dakis. 1993. Memory for spatial locations, motor responses, and objects: triple dissociation among the hippocampus, caudate nucleus, and extrastriate visual cortex. Experimental Brain Research 93(3): 462–470.
Packard, M.G., and J.L. McGaugh. 1992. Double dissociation of fornix and caudate nucleus lesions on acquisition of two water maze tasks: further evidence for multiple memory systems. Behavioral Neuroscience 106(3): 439.
Knowlton, B.J., J.A. Mangels, and L.R. Squire. 1996. A neostriatal habit learning system in humans. Science 273(5280): 1399–1402.
Schacter, D.L., and E. Tulving. 1994. Memory systems 1994: MIT Press.
Scoville, W.B., and B. Milner. 1957. Loss of recent memory after bilateral hippocampal lesions. Journal of Neurology, Neurosurgery and Psychiatry 20(1): 11.
Cacioppo, J.T., and L.G. Tassinary. 1990. Inferring psychological significance from physiological signals. American Psychologist 45(1): 16.
Ferrucci, R., and A. Priori. 2014. Transcranial cerebellar direct current stimulation (tcDCS): motor control, cognition, learning and emotions. NeuroImage 85: 918–923.
Boggio, P.S., L.P. Khoury, D.C. Martins, O.E. Martins, E. De Macedo, and F. Fregni. 2009. Temporal cortex direct current stimulation enhances performance on a visual recognition memory task in Alzheimer disease. Journal of Neurology, Neurosurgery & Psychiatry 80(4): 444–447.
Ferrucci, R., F. Mameli, I. Guidi, S. Mrakic-Sposta, M. Vergari, S. Marceglia, and A. Priori. 2008. Transcranial direct current stimulation improves recognition memory in Alzheimer disease. Neurology 71(7): 493–498.
Javadi, A.H., and P. Cheng. 2013. Transcranial direct current stimulation (tDCS) enhances reconsolidation of long-term memory. Brain Stimulation 6(4): 668–674.
Perlmutter, J.S., and J.W. Mink. 2006. Deep brain stimulation. Annual Review of Neuroscience 29: 229–257.
Hamani, C., M.P. McAndrews, M. Cohn, M. Oh, D. Zumsteg, C.M. Shapiro, and A.M. Lozano. 2008. Memory enhancement induced by hypothalamic/fornix deep brain stimulation. Annals of Neurology 63(1): 119–123.
Suthana, N., Z. Haneef, J. Stern, R. Mukamel, E. Behnke, B. Knowlton, and I. Fried. 2012. Memory enhancement and deep-brain stimulation of the entorhinal area. New England Journal of Medicine 366(6): 502–510.
Laxton, A.W., D.F. Tang‐Wai, M.P. McAndrews, D. Zumsteg, R. Wennberg, R. Keren, and G.S. Smith. 2010. A phase I trial of deep brain stimulation of memory circuits in Alzheimer's disease. Annals of Neurology 68(4): 521–534.
Wang, J.X., L.M. Rogers, E.Z. Gross, A.J. Ryals, M.E. Dokucu, K.L. Brandstatt, and J.L. Voss. 2014. Targeted enhancement of cortical-hippocampal brain networks and associative memory. Science 345(6200): 1054–1057.
Andén, N.E., A. Dahlström, K. Fuxe, K. Larsson, L. Olson, and U. Ungerstedt. 1966. Ascending monoamine neurons to the telencephalon and diencephalon. Acta Physiologica Scandinavica 67(3‐4): 313–326.
Dahlström, A., and K. Fuxe. 1964. Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons. Acta Physiologica Scandinavica. Supplementum, SUPPL 232: 231.
Zilles, K., and K. Amunts. 2009. Receptor mapping: architecture of the human cerebral cortex. Current Opinion in Neurology 22(4): 331–339. doi:10.1097/WCO.0b013e32832d95db.
Zilles, K., N. Palomero-Gallagher, C. Grefkes, F. Scheperjans, C. Boy, K. Amunts, and A. Schleicher. 2002. Architectonics of the human cerebral cortex and transmitter receptor fingerprints: reconciling functional neuroanatomy and neurochemistry. European Neuropsychopharmacology 12(6): 587–599.
Lynch, G. 2002. Memory enhancement: the search for mechanism-based drugs. Nature Neuroscience 5: 1035–1038.
Lynch, G., L.C. Palmer, and C.M. Gall. 2011. The likelihood of cognitive enhancement. Pharmacology, Biochemistry and Behavior 99(2): 116–129.
Bartus, R.T., R.L. Dean, B. Beer, and A.S. Lippa. 1982. The cholinergic hypothesis of geriatric memory dysfunction. Science 217(4558): 408–414.
Francis, P.T., A.M. Palmer, M. Snape, and G.K. Wilcock. 1999. The cholinergic hypothesis of Alzheimer’s disease: a review of progress. Journal of Neurology, Neurosurgery & Psychiatry 66(2): 137–147.
Corey-Bloom, J. 2003. Galantamine: a review of its use in Alzheimer's disease and vascular dementia. International Journal of Clinical Practice 57(3): 219–223.
Hansen, R.A., G. Gartlehner, A.P. Webb, L.C. Morgan, C.G. Moore, and D.E. Jonas. 2008. Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer’s disease: a systematic review and meta-analysis. Clinical Interventions in Aging 3(2): 211.
Lanctôt, K.L., N. Herrmann, K.K. Yau, L.R. Khan, B.A. Liu, M.M. LouLou, and T.R. Einarson. 2003. Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis. Canadian Medical Association Journal 169(6): 557–564.
Tariot, P.N., P. Solomon, J. Morris, P. Kershaw, S. Lilienfeld, and C. Ding. 2000. A 5-month, randomized, placebo-controlled trial of galantamine in AD. Neurology 54(12): 2269–2276.
Trinh, N.-H., J. Hoblyn, S. Mohanty, and K. Yaffe. 2003. Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysis. Jama 289(2): 210–216.
Repantis, D., O. Laisney, and I. Heuser. 2010. Acetylcholinesterase inhibitors and memantine for neuroenhancement in healthy individuals: a systematic review. Pharmacological Research 61(6): 473–481.
Rokem, A., and M.A. Silver. 2010. Cholinergic enhancement augments magnitude and specificity of visual perceptual learning in healthy humans. Current Biology 20(19): 1723–1728.
Bassett, D.S., and E. Bullmore. 2006. Small-world brain networks. The Neuroscientist 12(6): 512–523.
Cacioppo, J. T., and Berntson, G. G. 2011. The Brain, Homeostasis, and Health. Balancing Demands of the Internal and External milieu. See Friedman, 121-137.
Weiss, N., F. Miller, S. Cazaubon, and P.-O. Couraud. 2009. The blood-brain barrier in brain homeostasis and neurological diseases. Biochimica et Biophysica Acta (BBA)-Biomembranes 1788(4): 842–857.
Hills, T., and R. Hertwig. 2011. Why aren’t we smarter already evolutionary trade-offs and cognitive enhancements. Current Directions in Psychological Science 20(6): 373–377.
Maslen, H., Faulmüller, N., and J. Savulescu. 2014. Pharmacological cognitive enhancement—how neuroscientific research could advance ethical debate. Frontiers in Systems Neuroscience, 8.
Brem, A.-K., P.J. Fried, J.C. Horvath, E.M. Robertson, and A. Pascual-Leone. 2014. Is neuroenhancement by noninvasive brain stimulation a net zero-sum proposition? NeuroImage 85: 1058–1068.
Farah, M.J., C. Haimm, G. Sankoorikal, and A. Chatterjee. 2009. When we enhance cognition with Adderall, do we sacrifice creativity? a preliminary study. Psychopharmacology 202(1-3): 541–547.
Iuculano, T., and R.C. Kadosh. 2013. The mental cost of cognitive enhancement. The Journal of Neuroscience 33(10): 4482–4486.
Sarkar, A., A. Dowker, and R.C. Kadosh. 2014. Cognitive enhancement or cognitive cost: trait-specific outcomes of brain stimulation in the case of mathematics anxiety. The Journal of Neuroscience 34(50): 16605–16610.
Kadosh, R.C. 2015. Modulating and enhancing cognition using brain stimulation: Science and fiction. Journal of Cognitive Psychology (ahead-of-print), 1-23.
Cabrera, L.Y., N.S. Fitz, and P.B. Reiner. 2015. Reasons for comfort and discomfort with pharmacological enhancement of cognitive, affective, and social domains. Neuroethics 8(2): 93–106.
Davis, N. J., and M. G. van Koningsbruggen. 2013. “Non-invasive” brain stimulation is not non-invasive. Frontiers in Systems Neuroscience, 7.
Yuschak, T. 2006. Advanced lucid dreaming. The power of supplements.
Yuschak, T. 2007. Pharmacological induction of lucid dreams. Published online.
Kolber, A.J. 2006. Therapeutic forgetting: the legal and ethical implications of memory dampening. Vanderbilt Law Review 59: 1561.
Adler, J.M., and H.E. Hershfield. 2012. Mixed emotional experience is associated with and precedes improvements in psychological well-being. PLoS ONE 7(4): e35633.
Bonanno, G.A. 2004. Loss, trauma, and human resilience: have we underestimated the human capacity to thrive after extremely aversive events? American Psychologist 59(1): 20.
Evers, K. 2007. Perspectives on memory manipulation: using beta-blockers to cure post-traumatic stress disorder. Cambridge Quarterly of Healthcare Ethics 16(02): 138–146.
Griffiths, R.R., and P.P. Woodson. 1988. Caffeine physical dependence: a review of human and laboratory animal studies. Psychopharmacology 94(4): 437–451.
Juliano, L.M., and R.R. Griffiths. 2004. A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features. Psychopharmacology 176(1): 1–29.
Nutt, D.J., L.A. King, W. Saulsbury, and C. Blakemore. 2007. Development of a rational scale to assess the harm of drugs of potential misuse. The Lancet 369(9566): 1047–1053.
Schultz, W., L. Tremblay, and J.R. Hollerman. 2000. Reward processing in primate orbitofrontal cortex and basal ganglia. Cerebral Cortex 10(3): 272–283.
Grace, A.A. 1995. The tonic/phasic model of dopamine system regulation: its relevance for understanding how stimulant abuse can alter basal ganglia function. Drug and Alcohol Dependence 37(2): 111–129.
Potenza, M.N. 2015. Perspective: behavioural addictions matter. Nature 522(7557): S62–S62.
Potenza, M.N., M.A. Steinberg, P. Skudlarski, R.K. Fulbright, C.M. Lacadie, M.K. Wilber, and B.E. Wexler. 2003. Gambling urges in pathological gambling: a functional magnetic resonance imaging study. Archives of General Psychiatry 60(8): 828–836.
Tamminga, C.A., and E.J. Nestler. 2006. Pathological gambling: focusing on the addiction, not the activity. American Journal of Psychiatry 163(2): 180–181.
Minzenberg, M.J., and C.S. Carter. 2008. Modafinil: a review of neurochemical actions and effects on cognition. Neuropsychopharmacology 33(7): 1477–1502.
Repantis, D., P. Schlattmann, O. Laisney, and I. Heuser. 2010. Modafinil and methylphenidate for neuroenhancement in healthy individuals: a systematic review. Pharmacological Research 62(3): 187–206.
Vincent, N. 2013. Enhancing responsibility. Neuroscience and legal responsibilty, 305–336.
Savulescu, J., and B. Foddy. 2011. Le Tour and failure of zero tolerance: time to relax doping controls. Enhancing human capacities. Wiley-Blackwell, Malden, 304-312.
Giordano, J. 2014. Neurotechnology in National Security and Defense: Practical Considerations, Neuroethical Concerns: CRC Press.
Greely, H.T. 2011. Of nails and hammers: human biological enhancement and U.S. Policy Tools. In J. Savulescu, R. t. Meulen & G. Kahane (Eds.), Enhancing Human Capacities (pp. 503-520): Wiley-Blackwell.
Lin, P., Mehlman, M., Abney, K., and J. Galliott. 2014. Super soldiers (Part 1): what is military human enhancement?. Global Issues and Ethical Considerations in Human Enhancement Technologies, 119.
Moreno, J.D. 2003. Neuroethics: an agenda for neuroscience and society. Nature Reviews Neuroscience 4(2): 149–153.
Moreno, J.D. 2006. Mind wars: brain research and national defense. Washington, DC: Dana Press.
Appel, J.M. 2008. When the boss turns pusher: a proposal for employee protections in the age of cosmetic neurology. Journal of Medical Ethics 34(8): 616–618.
Beddington, J., C.L. Cooper, J. Field, U. Goswami, F.A. Huppert, R. Jenkins, and S.M. Thomas. 2008. The mental wealth of nations. Nature 455(7216): 1057–1060.
de Sio, F. S., Faulmüller, N., and N. A. Vincent. 2014. How cognitive enhancement can change our duties. Frontiers in Systems Neuroscience, 8.
Goold, I., and H. Maslen. 2014. Must the surgeon take the pill? negligence duty in the context of cognitive enhancement. The Modern Law Review 77(1): 60–86.
Norton, M.I., and D. Ariely. 2011. Building a better America—one wealth quintile at a time. Perspectives on Psychological Science 6(1): 9–12.
Savulescu, J. 2009. Enhancement and fairness. Journal of Medical Ethics 33: 284–288.
Tremblay, S., J.-F. Lepage, A. Latulipe-Loiselle, F. Fregni, A. Pascual-Leone, and H. Théoret. 2014. The uncertain outcome of prefrontal tDCS. Brain Stimulation 7(6): 773–783.
Jie, F., Tiecheng, W., Yan, Y., Duc, B. H., and L. Xiaoping. 2013. A magnetic field projector for deep brain modulation. Paper presented at the Neural Engineering (NER), 2013 6th International IEEE/EMBS Conference on.
Loveman, E., Green, C., Kirby, J., Takeda, A., Picot, J., Payne, E., and A. Clegg. 2006. The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer’s disease.
Fraix, V., J. Houeto, C. Lagrange, C. Le Pen, P. Krystkowiak, D. Guehl, and L. Defebvre. 2006. Clinical and economic results of bilateral subthalamic nucleus stimulation in Parkinson’s disease. Journal of Neurology, Neurosurgery & Psychiatry 77(4): 443–449.
Green, A., C. Joint, H. Sethi, P. Bain, and T. Aziz. 2004. Cost analysis of unilateral and bilateral pallidotomy for Parkinson's disease. Journal of Clinical Neuroscience 11(8): 829–834.
Erler, A. 2011. Does memory modification threaten our authenticity? Neuroethics 4(3): 235–249.
Earp, B.D., A. Sandberg, G. Kahane, J. Savulescu, B. Earp, A. Sandberg, and J. Savulescu. 2014. When is diminishment a form of enhancement? rethinking the enhancement debate in biomedical ethics. Name: Frontiers in Systems Neuroscience 8: 12.
Donovan, E. 2010. Propranolol use in the prevention and treatment of posttraumatic stress disorder in military veterans: forgetting therapy revisited. Perspectives in Biology and Medicine 53(1): 61–74.
Henry, M., J.R. Fishman, and S.J. Youngner. 2007. Propranolol and the prevention of post-traumatic stress disorder: is it wrong to erase the “sting” of bad memories? The American Journal of Bioethics 7(9): 12–20.
Conrad, P. 2008. The medicalization of society: On the transformation of human conditions into treatable disorders: JHU Press.
Elliott, C. 2004. Better than well: American medicine meets the American dream: WW Norton & Company.
Frances, A. 2013. Saving normal: an insider’s revolt against out-of-control psychiatric diagnosis, DSM-5, big pharma and the medicalization of ordinary life. Psychotherapy in Australia 19(3): 14.
Elliott, C. 1999. A philosophical disease: Bioethics, culture, and identity: Psychology Press.
Levy, N. 2007. Neuroethics: Challenges for the 21st century. Cambridge: Cambridge University Press.
Cahill, L., and M.T. Alkire. 2003. Epinephrine enhancement of human memory consolidation: interaction with arousal at encoding. Neurobiology of Learning and Memory 79(2): 194–198.
Cahill, L., L. Gorski, and K. Le. 2003. Enhanced human memory consolidation with post-learning stress: interaction with the degree of arousal at encoding. Learning & Memory 10(4): 270–274.
LaBar, K.S., and E.A. Phelps. 1998. Arousal-mediated memory consolidation: role of the medial temporal lobe in humans. Psychological Science 9(6): 490–493.
Nehlig, A., J.-L. Daval, and G. Debry. 1992. Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Research Reviews 17(2): 139–170.
Smith, M.E., and M.J. Farah. 2011. Are prescription stimulants “smart pills”? the epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals. Psychological Bulletin 137(5): 717.
Wilens, T.E. 2006. Mechanism of action of agents used in attention-deficit/hyperactivity disorder. Journal of Clinical Psychiatry 67: 32.
Foster, J.K., and M.E. Jelicic. 1999. Memory: Systems, process, or function? : Oxford University Press.
Roediger III, H.L. 2003. Reconsidering implicit memory. In: Bowers, J.S. and Marsolek, C.J. (eds.), Rethinking implicit memory. pp. 3-18. New York: Oxford University Press.
Tulving, E. 2007. Are there 256 different kinds of memory. The foundations of remembering: Essays in honor of Henry L. Roediger, III, 1, 39-52.
Simons, D.J., and C.F. Chabris. 2011. What people believe about how memory works: a representative survey of the US population. PLoS ONE 6(8): e22757.
Fitz, N.S., and P.B. Reiner. 2013. The challenge of crafting policy for do-it-yourself brain stimulation. Journal of medical ethics, medethics-2013-101458.
Cabrera, L. Y., Fitz, N. S., and Reiner, P. B. 2014. Empirical support for the moral salience of the therapy-enhancement distinction in the debate over cognitive, affective and social enhancement. Neuroethics, 1–14.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fox, K.C.R., Fitz, N.S. & Reiner, P.B. The Multiplicity of Memory Enhancement: Practical and Ethical Implications of the Diverse Neural Substrates Underlying Human Memory Systems. Neuroethics 10, 375–388 (2017). https://doi.org/10.1007/s12152-016-9282-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12152-016-9282-7